1. United States
2. Colo.
3. Letter

I am writing as your constituent to strongly oppose the proposed cuts to HIV research, prevention, and care in the FY2027 federal budget request. Recent analysis shows these cuts would reduce domestic HIV funding by roughly one-third, eliminating or weakening critical programs that millions of Americans rely on. This includes major reductions to CDC prevention efforts and threats to the stability of the Ryan White HIV/AIDS Program—both of which are essential for testing, treatment, and ongoing care. These are not marginal programs. They are the infrastructure that allows people to know their status, access life-saving medications, and prevent further transmission. Weakening them will not save money in the long run—it will increase infections, worsen health outcomes, and drive up future healthcare costs. Cuts to NIH-supported HIV research are equally alarming. The United States has led the world in HIV innovation for decades. Scaling back now risks slowing progress at a moment when ending the epidemic is within reach. This is not just a budget decision—it is a moral one. Reducing funding sends a clear message about whose health is prioritized and whose is not. The consequences will fall disproportionately on vulnerable communities who already face barriers to care. We know what works: sustained, evidence-based investment. We have the tools to significantly reduce HIV transmission and improve quality of life for those living with HIV. Abandoning that progress now would be a profound and preventable setback. I urge you to reject these cuts, protect HIV funding across prevention, care, and research, and uphold a commitment to public health grounded in science and equity.